Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home
31 items matching your search terms.
Filter the results.
Item type














New items since



Sort by relevance · date (newest first) · alphabetically
Su awarded NIH grant to develop immune therapies for hepatitis B
by William Shawn Davis (wishda) published Jul 19, 2013 last modified Jul 19, 2013 09:00 AM — filed under:
The National Institute of Health has awarded University of North Carolina researcher Lishan Su, PhD, with a $2 million four-year R01 grant to investigate using a novel immune therapy to treat chronic hepatitis B virus (HBV) infection.
Located in News
Survey of adolescent males and their parents shows low HPV vaccination rates
by William Shawn Davis published Aug 28, 2013 last modified Sep 04, 2013 03:53 PM — filed under:
Encouraging physicians to recommend human papillomavirus (HPV) vaccine to adolescent boys and their parents - and educating the boys and their families about the importance of receiving the vaccine - are essential to reducing the cancers this virus can cause.
Located in News
Transcription factors regulating blood oxygen linked to melanoma metastases
by William Shawn Davis published Apr 19, 2013 last modified May 08, 2013 02:40 PM — filed under:
Transcription factors regulating blood oxygen linked to melanoma metastases
Located in News
UNC Lineberger announces Marci Kramish Campbell Dissertation Award recipients
by William Shawn Davis (wishda) published Jul 17, 2013 last modified Jul 22, 2013 04:38 PM — filed under:
Shellie Ellis, MA, and Shelley Golden, PhD, of the Gillings School of Global Public Health are the 2013 recipients of the Marci Kramish Campbell Dissertation Award, a competitive $5,000 award to recognize excellence in dissertation research focused on cancer and the population sciences.
Located in News
UNC Lineberger members awarded grants from N.C. Biotechnology Center
by William Shawn Davis published Aug 23, 2013 last modified Aug 26, 2013 09:20 AM — filed under:
The North Carolina Biotechnology Center awarded more than $460,000 in grants to support research and infrastructure needs of members of the UNC Lineberger Comprehensive Cancer Center researching cancer and cell biology.
Located in News
UNC Lineberger members present at 2013 ASCO Annual Meeting
by William Shawn Davis (wishda) published Jun 05, 2013 last modified Jun 06, 2013 09:06 AM — filed under:
More than 15 members and associates of the UNC Lineberger Comprehensive Cancer Center presented their work to the attendees at the 2013 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
Located in News
UNC partners with NIH to explore genomic testing for newborns
by William Shawn Davis published Sep 04, 2013 last modified Sep 05, 2013 01:56 PM — filed under:
As the clinical use of genomic testing expands, the practical and ethical considerations of using the technology to screen newborns for genetic conditions will be the focus of a new study undertaken at the University of North Carolina.
Located in News
UNC-Malawi cancer pathology laboratory is a model for Sub-Saharan Africa
by Megan Fazekas-King (fazekask) published Aug 08, 2013 last modified Aug 20, 2013 09:43 AM — filed under:
Since 2011, the University of North Carolina has partnered with the government of Malawi to establish a pathology laboratory in the nation’s capital, building on an existing decades-long collaboration. The laboratory has provided an invaluable service to patients and has also built capacity at a national teaching hospital, according to an analysis of the first 20 months of operation published August 7 online by PLOS ONE.
Located in News
UNC-Malawi cancer pathology laboratory is a model for Sub-Saharan Africa
by William Shawn Davis (wishda) published Aug 02, 2013 last modified Aug 08, 2013 10:13 AM — filed under:
Since 2011, the University of North Carolina has partnered with the government of Malawi to establish a pathology laboratory in the nation’s capital, building on an existing decades-long collaboration. The laboratory has provided an invaluable service to patients and has also built capacity at a national teaching hospital, according to an analysis of the first 20 months of operation published August 7 online by PLOS ONE.
Located in Old top news stories
Understanding multiple causes of racial disparities in breast cancer is essential
by William Shawn Davis published Sep 05, 2013 last modified Sep 18, 2013 09:49 AM — filed under:
Racial disparities in the treatment and outcome of breast cancer patients arise from a combination of biological, social and financial causes. Understanding how these complex factors influence interactions between patients and the medical community is key to reducing the gaps in treatment and mortality between racial groups, according to researchers at the University of North Carolina.
Located in News